Long-term follow-up of the safety of delayed-release dimethyl fumarate in RRMS: interim results from the ENDORSE extension study

被引：0
|
作者：
Pozzilli, C. [1 ]
Phillips, J. T. [2 ]
Fox, R. J. [3 ]
Selmaj, K. [4 ]
Zhang, R. [5 ]
Novas, M. [5 ]
Sweetser, M. T. [5 ]
Gold, R. [6 ]
机构：
[1] Univ Roma La Sapienza, I-00185 Rome, Italy
[2] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[3] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Med Univ Lodz, Lodz, Poland
[5] Biogen Idec Inc, Cambridge, MA USA
[6] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P066
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [1] Long-term follow-up of the safety of delayed-release dimethyl fumarate in RRMS: interim results from the ENDORSE extension study
    Pozzilli, C.
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Gold, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 709 - 709
  • [2] Long-term follow-up of the safety of delayed-release dimethyl fumarate in RRMS: interim results from the ENDORSE extension study
    Pozzilli, C.
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Zhang, R.
    Novas, M.
    Rana, J.
    Gold, R.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 247 - 247
  • [3] Safety profile of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: long-term interim results from the ENDORSE extension study
    Pozzilli, C.
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Gold, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 678 - 678
  • [4] Safety profile of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: long-term interim results from the ENDORSE extension study
    Pozzilli, C.
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Gold, R.
    JOURNAL OF NEUROLOGY, 2014, 261 : S439 - S439
  • [5] Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
    Gold, Ralf
    Arnold, Douglas L.
    Bar-Or, Amit
    Hutchinson, Michael
    Kappos, Ludwig
    Havrdova, Eva
    MacManus, David G.
    Yousry, Tarek A.
    Pozzilli, Carlo
    Selmaj, Krysztof
    Sweetser, Marianne T.
    Zhang, Ray
    Yang, Minhua
    Potts, James
    Novas, Mark
    Miller, David H.
    Kurukulasuriya, Nuwan C.
    Fox, Robert J.
    Phillips, Theodore J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 253 - 265
  • [6] Longer-term follow-up of the efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with RRMS: an integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Marantz, J.
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 263 - 263
  • [7] Long-term efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with RRMS: an integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 27 - 27
  • [8] Long-term efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with RRMS: an integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 95 - 96
  • [9] Six-year follow-up of delayed-release dimethyl fumarate in RRMS: integrated clinical efficacy data from the DEFINE, CONFIRM, and ENDORSE studies
    Hutchinson, M.
    Gold, R.
    Fox, R. J.
    Phillips, J. T.
    Bar-Or, A.
    Kappos, L.
    Zhang, R.
    Yang, M.
    Marantz, J.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 246 - 247
  • [10] Five-year follow-up of delayed-release dimethyl fumarate in RRMS: integrated clinical efficacy data from the DEFINE, CONFIRM, and ENDORSE studies
    Kurukulasuriya, N. C.
    Gold, R.
    Phillips, J. T.
    Bar-Or, A.
    Hutchinson, M.
    Kappos, L.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Fox, R. J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 116 - 117
12345